1. Home
  2. NEO vs DSL Comparison

NEO vs DSL Comparison

Compare NEO & DSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • DSL
  • Stock Information
  • Founded
  • NEO 2001
  • DSL 2013
  • Country
  • NEO United States
  • DSL United States
  • Employees
  • NEO N/A
  • DSL N/A
  • Industry
  • NEO Precision Instruments
  • DSL Trusts Except Educational Religious and Charitable
  • Sector
  • NEO Health Care
  • DSL Finance
  • Exchange
  • NEO Nasdaq
  • DSL Nasdaq
  • Market Cap
  • NEO 1.2B
  • DSL 1.3B
  • IPO Year
  • NEO 1999
  • DSL N/A
  • Fundamental
  • Price
  • NEO $8.04
  • DSL $12.13
  • Analyst Decision
  • NEO Buy
  • DSL
  • Analyst Count
  • NEO 9
  • DSL 0
  • Target Price
  • NEO $13.31
  • DSL N/A
  • AVG Volume (30 Days)
  • NEO 3.1M
  • DSL 391.5K
  • Earning Date
  • NEO 04-29-2025
  • DSL 01-01-0001
  • Dividend Yield
  • NEO N/A
  • DSL 10.95%
  • EPS Growth
  • NEO N/A
  • DSL N/A
  • EPS
  • NEO N/A
  • DSL N/A
  • Revenue
  • NEO $672,361,000.00
  • DSL N/A
  • Revenue This Year
  • NEO $13.05
  • DSL N/A
  • Revenue Next Year
  • NEO $11.18
  • DSL N/A
  • P/E Ratio
  • NEO N/A
  • DSL N/A
  • Revenue Growth
  • NEO 10.10
  • DSL N/A
  • 52 Week Low
  • NEO $6.08
  • DSL $10.58
  • 52 Week High
  • NEO $19.11
  • DSL $13.24
  • Technical
  • Relative Strength Index (RSI)
  • NEO 43.86
  • DSL 54.58
  • Support Level
  • NEO $7.66
  • DSL $12.02
  • Resistance Level
  • NEO $8.31
  • DSL $12.18
  • Average True Range (ATR)
  • NEO 0.76
  • DSL 0.13
  • MACD
  • NEO -0.01
  • DSL 0.06
  • Stochastic Oscillator
  • NEO 45.94
  • DSL 91.34

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About DSL DoubleLine Income Solutions Fund of Beneficial Interests

DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.

Share on Social Networks: